Magnetic resonance imaging has become a widely used clinical tool for the assessment of neurologic symptoms, as well as being increasingly used in neuroscience research. White matter hyperintensities are common ndings on brain imaging and their discovery leads to questions about best management, especially when ndings are incidental or not considered relevant to the patient's presentation. This review will discuss the varied causes of white matter hyperintensities, consider how best to distinguish between them radiologically, and when they might have potential clinical relevance.
Interpretation of magnetic resonance imaging (MRI) of the brain relies on knowledge of MRI techniques as well as both the anatomy and pathophysiology of the brain and appearances on different MR sequences. There are a number of normal white matter appearances that can be confused for white matter hyperintensities (WMH). Focal T2 hyperintensities that suppress on fl uid-attenuated inversion recovery (FLAIR) sequences and follow cerebrospinal fl uid on all sequences are suggestive of perivascular (Virchow Robin) spaces, a common fi nding (Figure 1 a,b) . Ependymitis granularis, a T2 hyperintense rim surrounding the lateral ventricular margin on FLAIR imaging is often seen and is due to breakdown of the ependymal lining and gliosis, but is of no clinical signifi cance ( Figure 2 ). In children and younger adults, terminal zones of myelination, seen as areas of mild T2 hyperintensity in peri-atrial regions, can still be visible until myelination completes and can be easily confused with pathology ( Figure 3 ).
White matter appearances change with age and it is important to distinguish normal appearances from pathologic fi ndings, to avoid patient anxiety and unnecessary investigations. Occasional WMH are commonplace, most often within deep white matter. 1 These increase with age: in asymptomatic individuals, lesions are found in up to 11% by the fourth decade and 83% in the seventh decade. Variation is seen between individuals, likely refl ecting past medical history and vascular risk factors. When these WMH are examined microscopically, appearances are of myelin pallor, loss of myelin and axons, tissue rarefaction and mild gliosis. 2, 3 The differential diagnosis of WMH is wide and depends on location, appearance and changes over time (Table 1) . There are many potential causes including ischaemic, infl ammatory, demyelinating, metabolic, toxic and malignant. Neuroimaging protocols can be targeted to assess the white matter and assist in narrowing the differential diagnosis. White matter changes are best seen on both T2-weighted and FLAIR sequences. The latter are particularly helpful when assessing WMH that lie close to the ventricular margin or the cortex, as nulling of signal from cerebrospinal fl uid increases lesion conspicuity. Sagittal or 3D acquired FLAIR sequences can be helpful in detection of multiple sclerosis, improving detection of subtle foci, for example in the corpus callosum. Diffusionweighted imaging, including both a trace image and an apparent diffusion coeffi cient map, is important for identifying recent infarcts, while T2* susceptibility-weighted imaging (or T2*-weighted gradient-recalled echo if susceptibility-weighted imaging is not available) allow detection of microbleeds, fi ndings that point to a vascular aetiology.
Patterns of white matter disease that may give a clue to underlying aetiology should be considered, alongside the age and presenting symptoms. Periventricular WMH are common in both multiple sclerosis and small vessel ischaemia. With multiple sclerosis, WMH show a characteristic ovoid 1 Consultant Neuroradiologist, NHS Greater Glasgow and Clyde and Honorary Senior Lecturer, University of Glasgow, Glasgow, UK Figure 4) , with foci adjacent to the temporal horn, almost pathognomic of demyelination. By contrast, ischaemic WMH tend to show a broad base along the ventricular margin ( Figure 5 ). In both conditions, periventricular lesions increase and become more confl uent over time. Demyelinating foci have a predilection for the corpus callosum, especially inferiorly, at the callosal-septal interface, while ischaemic lesions are rarer. Granulomatous or infl ammatory conditions such as sarcoid also quite commonly show corpus callosal lesions. Foci in the juxtacortical white matter are most common with demyelination ( Figure 6 ), although are also common in vasculitis with changes occurring at the grey-white matter junction.
While occasional WMH are a normal observation with increasing age, multifocal WMH in an older adult are most suggestive of microvascular ischaemia. These changes are thought to arise from chronic hypoperfusion of the white matter and disruption of the blood-brain barrier, with chronic leakage of plasma into the white matter. 4 Often seen in association with silent brain infarcts and microbleeds, the number and extent of WMH increases with age, hypertension, hypercholesterolemia, diabetes and genetic risk factors, in particular the APOE*E4 genotype. 5 There has been a wide variation in radiologic terms to describe these white matter changes and in an attempt to unify, the term 'WMH of presumed vascular origin' has been suggested (STRIVE: Standards for Reporting Vascular Changes on Neuroimaging). 6 Grading scales can be useful to assess both disease extent and prognosis of WMH of presumed vascular origin. The Fazekas grading scale (grade 1-4) is widely used, 7 ranging from no or minimal white matter foci (grade 1) to confl uent deep white matter changes (grade 4). Intermediate grades are pathologic, but may be seen in normally functioning individuals. As WMH progress, patients become symptomatic, with prospective longitudinal studies showing that WMH predicts an increased risk of stroke, dementia, and death. The Leukoaraiosis And DISability study group (LADIS) looked at the impact of age-related brain white matter changes on the transition to disability in the elderly and found that severe white matter changes predict rapid global functional decline at 3 years. 8 The link between imaging appearances and function suggests that screening for risk factors of stroke and dementia may be useful in this patient group. 9 Multiple sclerosis should be considered as a possible cause for WMH, particularly in younger patients who have relevant symptoms and lesions in classic locations, disseminated in space and time. The MAGNIMS consensus guidelines 3 have recently updated the 2010 McDonald diagnostic criteria 10 ( Table 2 ). The optic nerve has been added as an additional site to the previous four defi ned locations classical for multiple sclerosis: periventricular (Figure 4) , juxtacortical ( Figure 6 ), infratentorial ( Figure 7 ) and spinal cord ( Figure  8 ), refl ecting that 25% of patients with a clinically isolated syndrome present with acute optic neuritis. The juxtacortical location now also includes the cortex as, with imaging advances, more foci are being identifi ed in this location.
Specifi city has improved with an increased requirement of three lesions in a periventricular location to meet criteria. The requirement of being able to identify which lesion is symptomatic has been removed. In addition to obtaining high quality brain imaging, contrast administration may be diagnostically useful, to separate acute enhancing from chronic non-enhancing lesions, allowing the dissemination in time criterion to be met in a single MRI. Further, spine MRI can provide a useful adjunct in patients who do not otherwise meet the dissemination in space criterion (Figure 8 ). Uncertainty may arise if WMH suggestive of multiple sclerosis are incidentally identifi ed on MRI brain performed for another clinical indication or as part of a research study. In this 'radiologically isolated syndrome', imaging abnormalities that suggest multiple sclerosis are found in a patient's brain and/or spinal cord, but the patient has not experienced any symptoms, meaning that a diagnosis of multiple sclerosis cannot be made. Okuda and colleagues performed a multinational retrospective review, showing that over a 5-year period up to 34% of such patients go on to have their fi rst clinical symptoms and receive a diagnosis of multiple sclerosis. 11 This suggests that clinical follow up is warranted in this group.
The differential diagnosis of WMH extends beyond multiple sclerosis, age-related changes and small vessel disease (Table 1) . In young patients with white matter foci, consider a history of migraine, given that there is an increase in deep white matter foci in migraineurs, especially those with aura. The exact cause of these white matter foci is unclear, but may refl ect changes in blood fl ow. 12 Other causes are more unusual but should be considered in the appropriate clinical setting. Non-atheromatous vasculopathy may arise secondary to underlying systemic conditions such as systemic lupus erythematous, or as a primary entity, CNS angiitis (isolated vasculitis of the central nervous system). Imaging appearances are those of WMH, often with cortical or juxtacortical involvement, and occasionally with haemorrhage. Vascular imaging techniques may be helpful to look for multifocal vascular narrowing due to vessel wall thickening.
Imaging of WMH is likely to further improve with advances in MR technology. Sensitivity to WMH is increased by the use of higher magnetic fi eld strengths, such as 3 Tesla, now • Asymptomatic Gd-enhancing and • Non-enhancing lesions at any time in routine clinical use, but in time likely also ultra-high fi eld strengths such as 7 Tesla, which may also offer improvements in specifi city. These magnets provide a stronger MR signal and improved resolution, allowing better detection of both white and grey matter foci 13, 14 offering earlier diagnosis and resultant treatment. MR sequences are constantly evolving and imaging protocols are likely to signifi cantly change over time. Sensitivity to WMH is improved both by magnetisation transfer imaging, 15 and diffusion tensor imaging, which can detect lesions that would otherwise go undetected by conventional techniques. 16 MRI is an invaluable technique for diagnosis of white matter disease, with detection of both symptomatic and asymptomatic disease. While this creates challenges in managing patients with unsuspected WMH, it also offers an opportunity of early diagnosis and potential early intervention. 
